| Views | |
|---|---|
| Targeted treatment in a case series of AR+, HRAS/PIK3CA co-mutated salivary duct carcinoma | 122 |
| July 2025 | August 2025 | September 2025 | October 2025 | November 2025 | December 2025 | January 2026 | |
|---|---|---|---|---|---|---|---|
| Targeted treatment in a case series of AR+, HRAS/PIK3CA co-mutated salivary duct carcinoma | 4 | 2 | 7 | 23 | 9 | 2 | 7 |
| Views | |
|---|---|
| 2024_Rieke_etal.pdf | 80 |
